Good Samaritan Society - Forest City Medicare and Medicaid Location: 606 South Seventh Street, Forest City, Iowa 50436 Ratings: Phone: (641) 585-2232 |
News Archive
Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.
Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.
Low back pain (LBP) is no stranger to office workers. In Japan, 1 out of 10 otherwise healthy office workers suffer from LBP. Stretching and exercise help alleviate the pain, but workers often do this when it is too late. But what if our chairs could alert us before the pain worsens?
Scientists have overcome a key barrier to the clinical use of stem cells with a technique which transforms regular body cells into artificial stem cells without the need for introducing foreign genetic materials, which could be potentially harmful. The research, published in STEM CELLS, suggests that cells taken from a patient's eye can be "reprogrammed" to replace or restore cells lost to degenerative diseases.
The Medicines and Healthcare products Regulatory Agency (MHRA) issued new advice to patients and doctors about the group of antidepressants known as SSRI's, today.
› Verified 5 days ago